This article is available online at http://www.jlr.org states and may be linked to other abnormalities in liver metabolism and function. Indeed, in a subset of individuals, hepatic steatosis can progress to liver injury, dysfunction, and failure. Intrahepatic lipid accumulation is also usually highly correlated with systemic insulin resistance, hyperglycemia, dyslipidemias, and risk of cardiovascular disease. Hepatic steatosis is extremely prevalent in obese individuals, and with the epidemic of obesity, the occurrence of nonalcoholic fatty liver disease has risen dramatically, becoming the most common cause of liver disease in the United States ( 1, 2 ).
Medicine and fulfi lled National Institutes of Health requirements for humane care. Generation of mice with liver-specifi c lipin 1 defi ciency (Alb-Lpin1
Ϫ / Ϫ mice) has been previously described ( 7, 33 ) . Fasting studies were timed so that mice were euthanized at 0800, which was 2 h after the end of the dark cycle. Food removal was timed accordingly to achieve the desired duration of fasting. To induce hepatic steatosis, mice were placed on a diet enriched with fat (40% kcal, mainly trans -fat; trans -oleic and translinoleic acids), cholesterol (2% weight [wt.]), and fructose (22% wt.) (HTF-C diet) (D09100301, Research Diets Inc.), which has been demonstrated to cause hepatic injury and infl ammation ( 34 ) . Mice were euthanized and tissues were harvested at the end of week 10 of the study after a 4 h fast. Liver, gonadal, and subcutaneous fat tissue samples were frozen in liquid nitrogen and stored at Ϫ 80°C.
Glucose tolerance test
The week prior to being euthanized, mice were fasted for 6 h, and tails were snipped to measure baseline blood glucose using a One-Touch Ultra glucometer (Life Scan Inc.). Following an overnight fast, a 10% D -glucose solution (1 g/kg) was administered via intraperitoneal injection and 30, 60, and 120 min after injection, and total area under the curve was calculated.
Protein isolation and Western blotting
Protein from frozen tissue was homogenized in 0.3-1 ml icecold homogenization buffer [25 mM HEPES, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, pH 8.0, supplemented with 1 mM activated Na 3 VO 4 , 1 mM phenylmethanesulfonyl fl uoride, 5 mM sodium fl uoride, and 1× Complete protease inhibitor cocktail tablet (Roche, Manneheim, Germany; cat. 04693116001)] using high-speed tissue disruption with the TissueLyser II (Qiagen, Valencia, CA). Tissue homogenates were subsequently solubilized by rotating at 4°C at 50 rpm for 1 h before being centrifuged (15,000 g for 15 min at 4°C) and collecting the supernatant. Protein from cultured cells were isolated by scraping adherent cells from culture plates, collecting them in the same homogenization buffer described above, and dispersing them via pipetting. Aliquots of the lysate from tissues and cultured cells were used to determine protein concentration by the bicinchoninic acid assay according to the manufacturer's instructions (Pierce Biotechnology; no. 23227). The remaining lysates were stored at Ϫ 80°C until further analyzed.
Lysates were subjected to SDS-PAGE and transferred to polyvinylidene difl uoride membranes. Blots were then rinsed with Trisbuffered saline plus Tween (TBST; 0.14 M NaCl, 0.02 M Tris base, pH 7.6, and 0.1% Tween), blocked with 5% BSA in TBST for 1 h at room temperature, washed 3 × 10 min at room temperature, and incubated with the relevant primary antibody 1:1,000 in 5% BSA overnight at 4°C. Blots were then washed 3 × 5 min with TBST, incubated with relevant secondary antibodies for 1 h at room temperature, washed again 3 × 10 min with TBST, and washed 2 × 10 min with TBS. Protein bands were visualized using the Odyssey Imaging System (LiCor Biosciences, Lincoln, NE). Lipin 1 (cat. sc-98450) antibody was obtained from Santa Cruz Biotechnology (Dallas, TX). Lipin 2 antibody has been previously described ( 21 ) . Anti-␣ -Tubulin Clone B-5-1-2 (cat. T5168) was purchased from Sigma-Aldrich (St. Louis, MO). Goat anti-mouse IRDye 680 (cat. 926-32220), goat anti-rabbit IRDye 680 (cat. 926-68021), and goat anti-rabbit 800 (cat. 926-32211) secondary antibodies were obtained from LiCor Biosciences. Akt (cat. 9272), phospho-Akt Ser473 (cat. 9271), phospho-Akt Thr308 (cat. 9275), glycogen synthase kinase (GSK)-3 ␤ (cat. 9315), and phospho-GSK-3 ␤ Ser9 (cat. 9323) were obtained from Cell Signaling (Danvers, MA ).
DNA-bound transcription factors to regulate their activity ( 14 ) . Lipin 1 coactivates the PPARs ( 14-16 ) and hepatic nuclear receptor 4 ␣ (HNF4 ␣ ) ( 17 ) nuclear receptors but represses nuclear factor of activated T-cells 4c ( 18 ) and the sterol-response element binding protein 1 [SREBP1; ( 19 ) ]. As a general rule, the transcriptional regulatory effects of lipin 1 do not require intact PAP catalytic activity and are mechanistically separable. The outlier to this generalization is repression of SREBP1, which requires both PAP activity and nuclear localization of lipin 1 ( 19 ) . Thus, lipin 1 is poised to regulate intermediary fat metabolism at multiple regulatory levels.
Mice constitutively lacking lipin 1 [fatty liver dystrophic ( fl d ) mice] exhibit very low PAP activity in most tissues, but because lipin 2 is highly expressed in liver, signifi cant hepatic PAP activity can be detected in fl d mice ( 4, 20 ) . Indeed, lipin 2 likely encodes a signifi cant proportion of hepatic PAP activity ( 21, 22 ) . However, hepatic lipin 1 expression is robustly induced by a variety of metabolic stimuli that signal the need for increased PAP activity including fasting ( 14, 23 ) , glucocorticoids and cAMP signaling ( 14, 23 ) , experimental ethanol administration ( 24 ) , sterols ( 25 ) , and liver regeneration ( 26 ) . These fi ndings are congruent with older data, generated before the cloning of lipins, that detected increased PAP activity in response to these stimuli (27) (28) (29) (30) . Because lipin 1 has the highest intrinsic PAP activity of the lipin family proteins ( 4 ), the induction of lipin 1 expression by these stimuli fi ts with this being an adaptive response to augment the hepatic capacity for TG synthesis in response to increased supply of fatty acids. In support of this, the fasting-induced increase in hepatic PAP activity is markedly blunted in fl d mice ( 20 ) .
The caveat to interpreting results from fl d mice is the profound lipodystrophic phenotype ( 31, 32 ) and its effects on lipid availability and metabolism. The marked defi ciency in adipose tissue mass makes it diffi cult to isolate the effects of hepatic lipin 1 on liver TG metabolism. Recently, mice expressing a conditional allele of lipin 1 have been developed ( 8 ) . These mice express, in a tissue-specifi c manner, lipin 1 protein that is N-terminally truncated and lacks PAP activity but retains its ability to coactivate PPAR ␣ ( 7 ) . Herein, we show that mice expressing this allele in a liver-specifi c manner exhibit signifi cant reductions in hepatic PAP activity but have normal rates of TG synthesis, and steady-state hepatic TG levels are unaffected. The ability of the truncated protein encoded by this allele to activate expression of fatty acid oxidation enzymes was intact. Collectively, these data demonstrate that marked defi cits in hepatic PAP activity do not impair TG synthesis and accumulation under acute or chronic conditions of lipid overload. deprotonated ions with those of internal standard in the negative-ion mode.
Hepatocyte isolation and in vitro studies

Hepatocytes from WT and Alb -Lpin1
Ϫ / Ϫ mice were isolated as previously described ( 38 ) and cultured in DMEM containing 5% FBS for 4 h, followed by a further 1 h incubation period in
Quantitative RT-PCR analyses
For all analyses, total RNA from liver or hepatocytes was isolated in RNAzol (Invitrogen) reagent. RNA (500 ng) was subjected to reverse transcription and SYBR GREEN RT-PCR (Applied Biosystems) following the manufacturer's instructions. Results were corrected to the expression of 36B4. Sequence of gene-specifi c primers is available upon request.
PAP activity
The method to assess PAP was modifi ed from Martin et al. ( 35 ) . Approximately 50 mg of liver tissue was homogenized in 1 ml of lysis buffer [0.01 M Tris-HCl (pH 7.3), 0.25 M Sucrose, 0.5% Tween-20, 1 mM DTT, 1× EDTA-free protease inhibitor (Roche, Manneheim, Germany; cat. 04693132001)] using a Tissue Master-125. Following homogenization, aliquots of the supernatant were used to determine protein concentration by the bicinchoninic acid assay. The [ 14 C]PA used was prepared as follows: 15 µl 0.1 mCi/ml of the [
]PA) (American Radiolabeled Chemicals Inc., St. Louis, MO; cat. 1303) was added to 3 mM 3-sn -PA sodium salt (Sigma Aldrich; cat. P9511) and 2 mM L -␣ -phosphatidylcholine (Sigma Aldrich; cat. P3556) in 1 ml of chloroform, evaporated under a stream of N 2 , and resuspended in 1 ml of ice cold distilled deionized water . This mixture was sonicated 3 × 10 s and kept on ice in between sonications. To run the assay reaction, 5 µl of each sample was incubated with 40 µl of assay buffer [0.1 M Tris/maleate (pH 6.9), 10 mM MgCl 2 , 0.2% fatty acid-free BSA, 1 mM DTT, and 1× EDTA-free protease inhibitor with or without 12.5 mM N -ethylmaleimide (Sigma Aldrich; cat. E3876)], and 5 µl of [ 14 
C]
PA was incubated at 37°C for 20 min. The reaction was stopped by adding 1 ml of a 19:1 (v/v) chloroform-methanol mixture containing 0.8% olive oil to each reaction and vortexing briefl y. Then 500 mg of activated aluminum oxide was added to the tubes and capped securely. Three cycles of vortexing for 30 s and being left undisturbed for 10 min followed. Samples were spun down at 10,000 g for 5 min, and 350 µl of sample was added to scintillation fl uid to count the 14 C radioactivity.
Liver lipid content
For fasting studies, liver TG content was determined from samples prepared in the PAP Activity assay buffer, solubilizing the homogenate 1:1 (v/v) with 1% sodium deoxycholate, vortexing, incubating at 37°C for 5 min, and then using the Infi nity TG Reagent (Thermo Fisher Scientifi c, Waltham, MA; cat: TR22421) as per the manufacturer's instructions.
For HTF-C studies, liver lipids were quantifi ed by using ESI/ MS analysis as described ( 36, 37 ) . In brief, lipids were extracted from mouse liver using a modifi ed Bligh and Dyer technique in the presence of internal standards. ESI/MS analyses were performed utilizing a TSQ Quantum Ultra Plus triple-quadrupole mass spectrometer (Thermo Fisher Scientifi c, San Jose, CA), or an LTQ Orbitrap mass spectrometer (Thermo Fisher Scientifi c, San Jose, CA), equipped with an automated nanospray apparatus (Nanomate HD; Advion Bioscience Ltd., Ithaca, NY). TG molecular species were analyzed using TSQ Quantum Ultra Plus triplequadrupole mass spectrometer in the positive-ion mode in the presence of a small amount of LiOH. Diglyceride molecular species were analyzed by derivatization with dimethylglycine and direct infusion in the presence of 0.1% formic acid, and ionized in the positive ion mode. Due to the low abundance of PA, PA molecular species were analyzed by using LTQ Orbitrap mass spectrometer at resolving powers (at m/z 400 Th) of 60,000 in full-scan mode and with the lock-mass feature engaged. Quantitative analysis of PA molecular species was performed by ratiometric comparisons of the intensities of the high mass accuracy (<5 ppm) PA 
RESULTS
Time course of fasting-mediated changes in lipin expression and PAP activity in liver
C57BL6/J mice were fasted for varying times, and PAP activity and lipin expression were characterized. Hepatic PAP activity was signifi cantly elevated at 4, 16, and 24 h after food removal ( Fig. 1A ). In contrast, N-ethylmaleimideinsensitive dephosphorylation of PA (lipid phosphate phosphatase) was not affected by fasting. Lpin1 and Lpin2 mRNA expression was signifi cantly increased at the 16 and 24 h time points ( Fig. 1B ) . Lpin3 mRNA expression was unaffected by fasting. Lipin 1 protein abundance was increased by 4, 16, or 24 h of fasting ( Fig. 1C ). Lipin 2 protein abundance was increased only by 16 and 24 h of fasting. These data indicate that the time course of the induction in hepatic PAP activity is well correlated with the expression of lipin 1 and lipin 2.
Generation of mice with loss of lipin 1 in liver
To generate mice with liver-specifi c lipin 1 defi ciency, mice harboring a Lpin1 allele with LoxP sites fl anking exons 3 and 4 were crossed with mice expressing Cre recombinase under control of the albumin promoter (Alb-Lpin1 Ϫ / Ϫ mice; Fig. 2A ). As expected, this led to a marked reduction in Lpin1 mRNA expression in Alb-Lpin1 Ϫ / Ϫ mice compared with littermate controls as early as postnatal day 8 (P8; Fig. 2B ). However, similar to our previous work with fl d mice ( 45 ), loss of lipin 1 did not reduce hepatic PAP activity at this point in development ( Fig. 2C ). Loss of lipin 1 specifi cally in liver also did not affect liver TG content at P8 ( Fig. 2D ). This is consistent serum-free DMEM. Triacylglycerol synthesis rates were quantifi ed by using [ 3 H]glycerol in the presence of 0.5 mM BSA-conjugated oleic acid as previously described ( 39 ) . Palmitate oxidation rates were assessed using [ 3 H]palmitate as previously described ( 38, 40 ) .
Lipin 1 adenoviral constructs
A mouse lipin 1 cDNA encoding a protein lacking the fi rst 115 amino acids ( ⌬ 115-lipin 1) has previously been described ( 7 ) . To construct an adenoviral expression vector, the truncated lipin 1 cDNA was subcloned into the AdTrack-cytomegalovirus shuttle vector and recombined using the AdEasy-1 system. The WT lipin 1 and control green fl uorescent protein (GFP) adenovirus constructs have been previously described ( 14 ) .
Transfection studies and luciferase reporter assays
HepG2 cells were maintained in DMEM-10% fetal calf serum. Transient transfections with luciferase reporter constructs were performed by calcium-phosphate coprecipitation. SV40-driven renilla luciferase expression construct was also included in each well. For all vectors, promoterless reporters or empty vector controls were included so that equal amounts of DNA were transfected into each well. Luciferase activity was quantifi ed 48 h after transfection by using a luminometer and the Stop and Glo® dual luciferase kit (Promega). Assays were performed in duplicate. To control for transfection effi ciency, fi refl y luciferase activity was corrected to renilla luciferase activity.
The 924 amino acid (WT lipin 1) and ⌬ 115-lipin 1 proteins were fused to an N-terminal triple hemagglutinin tag were overexpressed using a pCDNA3.1 vector ( 7 ) . The HNF4 ␣ (pMT-HNF4 ␣ ) has been described ( 41, 42 ) . Acadm .TKLuc ( 43, 44 ) was the gift of Daniel Kelly.
Statistical analysis
Statistical comparisons were made using ANOVA or t -test. All data are presented as the means ± SE, with a statistically significant difference defi ned as a P value <0.05. Fig. 3C ), suggesting that hepatic PAP activity is not highly limiting for TG synthesis even under fasted conditions. Indeed, for hepatocytes isolated from mice that were either fed or fasted prior to isolation, we found no difference in rates of TG synthesis between the WT control and the Alb-Lpin1 Ϫ / Ϫ mice ( Fig. 3D ). Loss of lipin-1-mediated PAP activity did not affect the plasma concentrations of glucose, TG, or NEFAs ( Table 1 ) .
Lipin 1 ⌬ 115 protein retains its transcriptional regulatory function in hepatocytes
We have recently shown that the truncated lipin 1 protein ( ⌬ 115-lipin 1) expressed in these mice retained its transcriptional regulatory function in promoter-luciferase reporter-based assays responsive to PPAR ␣ ( 7 ) . Overexpression of the ⌬ 115-lipin 1 protein was also suffi cient to activate the liver-enriched transcription factor HNF4 ␣ on the Acadm promoter-luciferase reporter ( Fig. 4A ), which we have shown to be a target of lipin 1 ( 17 ) . Consistent with this, adenovirus-mediated overexpression of lipin 1 WT or ⌬ 115 in WT hepatocytes induced the expression of several genes encoding fatty acid oxidation enzymes known to be targets of HNF4 ␣ and PPAR ␣ ( Fig. 4B ). Given these fi ndings with the truncation-producing allele, we next assessed the expression of several genes known to be under the control of lipin 1 in liver of mice under fed and with our previous work indicating that loss of lipin 1 in adipose tissue leads to postnatal steatosis ( 7 ) and suggests that this aspect of the phenotype of fl d mice is due to lipin 1 defi ciency in extrahepatic tissues.
The fasting-induced increase in PAP activity is attenuated in Alb-Lpin1 ؊ / ؊ mice without affecting TG content
At baseline, Western blotting detected no full-length protein in Alb-Lpin1 Ϫ / Ϫ mice, but a truncated lipin 1 protein was observed upon prolonged exposure ( Fig. 3A ) . We have shown that this truncated protein is the result of an alternative start codon in the fi rst intact exon and encodes a protein lacking the fi rst 115 amino acids ( ⌬ 115-lipin 1) ( 7 ) . When WT and Alb-Lpin1 Ϫ / Ϫ mice were fasted 16 h, the expression of WT and ⌬ 115-lipin 1 protein was markedly induced ( Fig. 3A ) . Lipin 2 protein abundance was moderately induced by fasting in liver and was increased in Alb-Lpin1 Ϫ / Ϫ mice compared with WT comparators ( Fig. 3A ) .
We have previously shown that the ⌬ 115 allele of lipin 1 is intrinsically defi cient in PAP activity ( 7 ) . Consistent with this, we detected a signifi cant decrease in hepatic PAP activity at baseline, and the fasting-induced increase in hepatic PAP activity was attenuated in Alb-Lpin1 Ϫ / Ϫ mice ( Fig. 3B ). Despite this, hepatic TG content was not affected by lipin 1 defi ciency under fed or fasted conditions insulin sensitivity and reduced hepatic steatosis ( 12 ) . Therefore, we assessed the effects of lipin-1-mediated PAP activity on a model of chronic lipid oversupply. A high-fat/fructose/cholesterol (HTF-C) diet, which is known to increase hepatic TG storage, was administered to WT and Alb-Lpin1 Ϫ / Ϫ mice. Weight gain on the HTF-C diet was not affected by genotype ( Fig. 5A ). Plasma insulin concentration was also unaffected by genotype, nor were the plasma concentrations of TG, NEFA, or cholesterol altered ( Table 2 ). In contrast to the previous report, liver-specifi c loss of lipin-1-mediated PAP activity did not affect glucose tolerance ( Fig. 5B ). We also found that insulin-stimulated phosphorylation of insulin signaling proteins was not affected by loss of lipin-1-mediated PAP activity ( Fig. 5C ). Histologic analyses demonstrated that HTF-C diet caused widespread lipid droplet accumulation and evidence of liver injury including hepatocyte ballooning and macrophage fasted conditions. The hepatic expression of several genes encoding fatty acid oxidation enzymes, which was significantly induced by fasting, was not different in liver of Alb-Lpin1 Ϫ / Ϫ mice compared with WT control mice ( Fig. 4C ) . Consistent with this, rates of palmitate oxidation in hepatocytes isolated from Alb-Lpin1 Ϫ / Ϫ mice were not different compared with control hepatocytes, even when mice were fasted prior to hepatocyte isolation to boost rates of oxidation ( Fig. 4D ) . These fi ndings indicate that liver-specifi c expression of lipin 1 ⌬ 115 protein leads to reduced PAP activity, but does not affect the expression of target genes encoding fatty acid oxidation enzymes.
Liver-specifi c loss of lipin-1-mediated PAP activity does not affect glucose tolerance or insulin sensitivity in HTF-C diet-fed mice
Previous work has suggested that inhibition of hepatic lipin 1 expression in high fat diet fed mice improved or total PA content ( Fig. 7B ) . Total DAG and TG content was not different in HTF-C-fed Alb-Lpin1 Ϫ / Ϫ mice compared with WT controls ( Fig. 7C, D ) . Additionally, there was no effect of genotype on specifi c DAG and TG species. Collectively, these fi ndings indicate that chronic, liverspecifi c defi ciency in lipin-1-mediated PAP activity does not impair the capacity of the liver for TG synthesis or the development of hepatic steatosis.
DISCUSSION
Lipin proteins have emerged as important regulators of hepatic intermediary metabolism via their enzymatic effects on TG biosynthesis as well as via nuclear effects on transcriptional regulation of metabolic enzymes. In this work, we characterized the phenotype of mice with liverspecifi c expression of an allele of lipin 1 that lacked PAP activity. Despite a reduction in PAP activity of >50% with infi ltration ( Fig. 6A ). These end points were not affected by genotype of the mice. We also assessed the hepatic expression of markers of liver injury, infl ammation, and stellate cell activation. However, we found no evidence for an effect of lipin-1-mediated PAP activity defi ciency on these parameters ( Fig. 6B ) .
As expected, hepatic PAP activity was markedly reduced, compared with WT mice, in Alb-Lpin1 Ϫ / Ϫ mice fed HTF-C diet ( Fig. 7A ). Loss of lipin-1-mediated PAP activity caused a strong trend toward accumulation of 18:0-18:1 PA species, but did not affect accumulation of other PA species Ϫ / Ϫ mice on HTF-C diet for 10 weeks is shown. B: Glucose tolerance was quantifi ed in WT and Alb-Lpin1 Ϫ / Ϫ mice fed HTF-C diet for 10 weeks. C: Hepatic insulin signaling was measured by Western blotting for phosphorylation of proteins in that signaling cascade. The quantifi cation of the normalized (WT saline = 1.0) ratio of phosphorylated to total protein abundance is shown in the graphs inset (n = 4). * P < 0.05 versus no insulin mice of the same genotype. described this phenomenon in fl d mice ( 21 ) , which is consistent with reciprocal regulation of lipin 1 and lipin 2 in liver and other cell types (51) (52) (53) . We found Alb-Lpin1 Ϫ / Ϫ mice retain suffi cient hepatic PAP activity for robust TG synthesis under fasting and high-fat diet fed conditions. This is consistent with the fi nding that ethanol-induced hepatic steatosis in Alb-Lpin1 Ϫ / Ϫ mice was not attenuated and actually exacerbated compared with WT control mice ( 33 ) . In contrast, acute RNAi-mediated lipin 1 or lipin 2 depletion in liver of mice has been reported to attenuate hepatic steatosis and improve insulin sensitivity ( 12, 13 ) . Again, it is possible that the lack of effect on these metabolic parameters in Alb-Lpin1 Ϫ / Ϫ mice is due to chronic compensatory mechanisms that arise due to long-term lipin 1 defi ciency or due to differences in dietary fat content or compositions used in the different studies.
Our previous work demonstrated that shRNA-mediated lipin 1 knockdown in liver blunted the increased expression of genes encoding fatty acid oxidation enzymes under fasting conditions ( 14 ) . This was also observed in fl d mouse liver after a shorter term fast (12 h) ( 49 ) . These data, together with evidence for direct transcriptional regulation by lipin 1, suggest that lipin 1 is an inducible loss of lipin 1, rates of TG synthesis and steady-state PA, DAG, and TG levels were unchanged even under conditions of chronic lipid overload. In contrast, knockdown of DAG acyltransferase (DGAT) 2, which catalyzes the step immediately downstream of lipin 1, with targeted antisense oligonucleotides led to a 50% reduction in DGAT activity, suppressed TG synthesis, and reduced steady-state TG content ( 46, 47 ) . Similarly, suppression of 50% of glycerol-3-phosphate acyltransferase activity, the fi rst step in this pathway, is also suffi cient to attenuate hepatic TG synthesis and steatosis ( 48 ) . These data, taken with previous work ( 21, 49 ) , suggest that PAP activity is far from limiting for regulating intrahepatic TG synthesis. However, we cannot exclude that chronic defi ciency in lipin-1-mediated PAP activity leads to compensatory mechanisms for synthesizing these glycerolipids.
The remaining PAP activity detected in the liver of Alb-Lpin1 Ϫ / Ϫ mice is likely catalyzed by lipin 2, which is an important hepatic PAP enzyme and is the most abundant lipin family member in the liver under most conditions ( 21, 22 ) . Although the intrinsic catalytic activity of lipin 2 is lower than lipin 1 ( 4 ), lipin 2 is subject to less regulation by phosphorylation ( 50 ) . Lipin 2 protein abundance was increased in Alb-Lpin1 Ϫ / Ϫ liver. We have previously to be markers of liver injury, macrophage infi ltration, and stellate cell activation in liver of WT and Alb-Lpin1 Ϫ / Ϫ mice on HTF-C diet for enhancer of hepatic fatty acid oxidation capacity via transcriptional mechanisms. The observation that Alb-Lpin1 Ϫ / Ϫ mice exhibited no defect in fasting-induced expression of genes encoding fatty acid oxidation enzymes is consistent with our observation that the ability to regulate PPAR ␣ ( 7 ) and HNF4 ␣ ( Fig. 4 ) is retained by the ⌬ 115 allele.
In conclusion, we show that loss of lipin-1-mediated PAP activity fails to constrain TG synthesis or reduce steadystate DAG and TG content of the liver under acute or chronic conditions of high fatty acid availability. Our data further support the idea that the PAP activity and nuclear receptor transcriptional regulatory activity of lipin 1 can be functionally separated. Additional work will be needed to defi ne the pathways and compensatory mechanisms that allow robust hepatic TG synthesis in the context of reduced PAP activity. 
